Life-Support patients get kidney protection trial
NCT ID NCT07438262
Summary
This study is testing whether giving amino acids (protein building blocks) through an IV drip can help prevent or reduce severe kidney injury in adults who are critically ill and on a life-support machine called ECMO. The trial will involve 40 patients across three hospitals, with half receiving the amino acid treatment and half receiving a placebo (inactive solution) for comparison. Researchers want to see if this short-term treatment, started within 24 hours of going on ECMO, can improve kidney function and outcomes for these very sick patients.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE KIDNEY INJURY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Alfred Hospital
Melbourne, Victoria, 3004, Australia
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-••••
Conditions
Explore the condition pages connected to this study.